Monday, September 26, 2022

Latest:

Celebrating advanced practice providers week
Reflections from a clinical ethics intern
National Postdoc Appreciation Week 2022
Healthy Habits: Dr. Ellen Friedman starts and ends the day with gratitude
From my Perspective: Dr. Debosmita Sardar shares her experiences during postdoctoral training

Baylor College of Medicine Blog Network

Home
Momentum
From The Labs
- About From the Labs
- Follow From The Labs on Twitter
Policywise
- About PolicyWise
- Follow @BCMEthics on Twitter
The Stitch
- About The Stitch
Progress Notes
bcm.edu

Acute Lymphoblastic Leukemia

From The Labs

Applying basic science helps predict poor treatment outcomes in ALL

November 21, 2019November 21, 2019Acute Lymphoblastic Leukemia, ALL, carbon metabolism, metabolome, Pediatric Cancer, prognosis, Research

The survival of patients with pediatric acute lymphoblastic leukemia (ALL) has significantly improved in the last several decades, but there is still a group of

From The Labs

Exploring the risk of ALL in children with Down syndrome

September 24, 2019September 24, 2019Acute Lymphoblastic Leukemia, ALL, CDKN2A gene, Childhood leukemia, Down syndrome, IKZF1 gene, Research

Acute Lymphoblastic Leukemia (ALL) is the most common childhood cancer. Children with trisomy 21 (Down syndrome) are 10 to 20 times more likely to develop ALL

From the Labs: RAIN-STORM 3D neuronal nanoscopic imaging